Dr. Fadi Tohme, MD

Dr. Tohme practices at DaVita Trc/usc Kidney Center in Los Angeles, California.

Dr. Tohme's NPI, 1336437730, was assigned on July 19, 2011. Dr. Tohme graduated from St Joseph's University Medical School in 2010. Dr. Tohme holds California license A172910.

Dr. Tohme's primary practice is DaVita Trc/usc Kidney Center, at 2310 Alcazar Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 441-9966.

Dr. Tohme's primary practice is DaVita Trc/usc Kidney Center in Los Angeles, California. Dr. Tohme is also affiliated with Keck Hospital of USC. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Tohme to 1 more hospital, 2 group practices and clinics, 1 dialysis center, 1 other site and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tohme practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Tohme's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Tohme is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Tohme's licenses on file in 5 states: California, Illinois, Missouri, Pennsylvania and Iowa.

Dmand AI lists acute kidney failure, chronic kidney disease and fluid and electrolyte imbalances among the conditions Dr. Tohme treats.

CMS data shows 687 Medicare services from Dr. Tohme across 9 procedure codes in 2024, for 271 Medicare patients. Medicare paid $57,421 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 271 Medicare patients who saw Dr. Tohme in 2024. The largest group is 65 to 74, with 122 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 59% are also on Medicaid. Their average risk score is 4.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tohme's median patient age at 64, with 44% women.

In 2024, Dr. Tohme wrote 495 Medicare Part D claims for 70 patients. 80% of them were for generic drugs. CMS names the drug for 299 of them, across 15 drugs with 11 or more claims each, at $63,815 in total drug cost. In 2023, CMS named 192 claims across 8 drugs.

Dr. Tohme accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tohme as offering telehealth.

Dmand AI links 1 paper to Dr. Tohme in 2017. Dr. Tohme's most frequent co-authors are Paul Marc Palevsky, MD and Steven Darrow Weisbord, MD, MS.

Dmand AI links Dr. Tohme to 1 clinical trial. Conditions studied include Hydronephrosis and Acute Kidney Injury.

CMS Open Payments shows 3 general payments to Dr. Tohme from 3 drug and device companies from 2018 to 2023. Food and beverage make up the largest share, 100% of the total. Aurinia Pharma U.S., Inc. paid the most, $121.

Dr. Tohme graduated from St Joseph's University Medical School in 2010. Dr. Tohme is a member of ASN and SCCM.

Dr. Tohme is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.